| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.1M | -44.7% | +115.0% |
| Cost of Revenue | $3.1M | -69.2% | +110.8% |
| Gross Profit | $3.0M | +243.0% | +119.6% |
| R&D Expense | $699K | +6.2% | +22.2% |
| SG&A Expense | $2.5M | +16.6% | +33.1% |
| Operating Income | -$221K | +88.5% | +79.7% |
| Pre-tax Income | -$188K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.4M | -24.2% | +679.1% |
| Accounts Receivable | $3.4M | -36.6% | +166.5% |
| Inventory | $8.9M | +13.0% | +17.6% |
| Current Assets | $21.6M | -13.7% | +70.8% |
| Total Assets | $47.2M | -2.9% | +71.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.3M | — | — |
| Capital Expenditures | $930K | — | — |
| Investing Cash Flow | -$5.7M | — | — |
| Financing Cash Flow | $926 | — | — |
| Free Cash Flow | -$6.2M | — | — |
| +89.4% |
| +84.2% |
| Net Income | -$188K | +89.4% | +84.2% |
| EPS (Basic) | -$0.01 | +88.9% | +91.7% |
| EPS (Diluted) | -$0.01 | +88.9% | +91.7% |
| $7.6M |
| -14.4% |
| +194.5% |
| Total Liabilities | $11.4M | -11.0% | +59.3% |
| Stockholders' Equity | $35.8M | +0.0% | +75.8% |